InvestorsHub Logo

XenaLives

12/29/16 12:01 PM

#85991 RE: Rubyred77 #85990

I would prefer a deal for 2-73 for Alzheimer's only.

McMagyar

12/29/16 12:26 PM

#85995 RE: Rubyred77 #85990

Rubyred, this would be the in-licensing deal..they'happen all the time
and IMO would be best for Anavex EARLY in deal as AVXL will not be capped on potential..BUT keep in mind..we have A3-71 right behind A2-73..whoever
gets A2-73 sure as heck wants A3-72!
It gets complicated fast..